ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Infection"

  • 2019 American Transplant Congress

    Efficacy and Safety of Alemtuzumab versus Basiliximab Induction in Lung Transplantation

    J. Choe, J. Au, A. Diamond, C. Ruggia-Check, S. Sehgal, F. Cordova, N. Shigemura, S. Keshavamurthy, Y. Toyoda

    Temple University Hospital, Philadelphia, PA

    *Purpose: Minimal literature exists regarding alemtuzumab for induction in lung transplantation but is the preferred agent at Temple University Hospital (TUH). Basiliximab is reserved for…
  • 2019 American Transplant Congress

    Infectious Complications of Eculizumab Use in Abdominal Organ Transplant Recipients

    A. M. Nolan1, E. J. Fraser2, H. K. Grewal3, J. G. Timpone3

    1Department of Pharmacy, Medstar Georgetown University Hospital, Washington, DC, 2Georgetown University School of Medicine, Washington, DC, 3Division of Infectious Diseases and Travel Medicine, Medstar Georgetown University Hospital, Washington, DC

    *Purpose: The purpose of this study is to identify and characterize infections in abdominal organ transplant recipients related to treatment with eculizumab. Eculizumab (Soliris®) is…
  • 2019 American Transplant Congress

    Infectious Complications in Tocilizumab-Treated Kidney Transplant Recipients

    S. Sethi, A. Peng, R. Najjar, A. Vo, S. Jordan, E. Huang

    Cedars Sinai Medical Center, Los Angeles, CA

    *Purpose: Tocilizumab blocks IL-6 signaling, inhibiting maturation of B cells to plasma cells and antibody production. We have used tocilizumab since 2012 to treat kidney…
  • 2019 American Transplant Congress

    Predictors of Clostridium difficile Infection and Recurrence among 2,622 Solid Organ Transplant Recipients

    A. Schluger, R. Rosenblatt, R. Knotts, E. Verna, M. Pereira

    Columbia University, New York, NY

    *Purpose: Clostridium difficile infection (CDI) is common after solid organ transplant (SOT) and is associated with high morbidity and mortality. We assessed incidence, risk factors…
  • 2019 American Transplant Congress

    What is the Post-Heart Transplant Risk of Infectious Complications from Pre-Transplant Desensitization Therapy?

    E. Kransdorf, J. Patel, S. Dimbil, R. Levine, D. H. Chang, J. A. Kobashigawa

    Cedars-Sinai Smidt Heart Institute, Los Angeles, CA

    *Purpose: Sensitization or the detection of circulating antibodies in heart transplant candidates appears to be increasing due to the growing use of mechanical circulatory support…
  • 2019 American Transplant Congress

    Epidemiology and Risk Factors of Early Post-Transplant Clostridium difficile Infection in Renal Transplant Recipients

    M. Jorgenson1, J. Descourouez1, D. Yang2, G. Leverson2, C. Saddler2, J. Smith2, R. Redfield2

    1UW Health, Madison, WI, 2University of Wisconsin School of Medicine and Public Health, Madison, WI

    *Purpose: To elucidate the epidemiology and peri-transplant risk of CDI*Methods: Retrospective review of adult renal transplant (RTX) recipients from 1/1/2012-12/31/2015. Primary objective was to describe…
  • 2019 American Transplant Congress

    Yellow Fever and Renal Transplantation: Influence of Vaccination and Infection on the Emergence of Antibody-Mediated Rejection

    M. V. Sousa1, R. L. Zollner2, R. S. Stucchi3, I. F. Boin4, E. C. Ataide4, M. Mazzali1

    1Department of Internal Medicine - Division of Nephrology, University of Campinas, Campinas, Brazil, 2Department of Internal Medicine, University of Campinas, Campinas, Brazil, 3Department of Internal Medicine - Division of Infectious Diseases, University of Campinas, Campinas, Brazil, 4Surgery Department, University of Campinas, Campinas, Brazil

    *Purpose: Yellow fever (YF) is a viral hemorrhagic disease transmitted by mosquitos, with variable clinical disease manifestations from a mild, undifferentiated febrile illness to severe…
  • 2019 American Transplant Congress

    Spontaneous Bacterial Peritonitis Prophylaxis Increases the Risk of Multi-Drug Resistant Cultures and Infections in Liver Transplant Patients

    R. Rosenblatt, A. Schluger, M. Pereira, E. Verna

    Columbia University Medical Center, New York, NY

    *Purpose: Spontaneous bacterial peritonitis prophylaxis (SBP-P) is increasingly prescribed to patients awaiting liver transplantation (LT), but its impact on multidrug resistant organisms (MDRO) or the…
  • 2019 American Transplant Congress

    Improving Medication Adherence and Outcomes in Adult Kidney Transplant Patients Using SystemCHANGETM: Results of the Medication Adherence Given Individual Change (MAGIC) Randomized Clinical Trial

    M. R. Wakefield1, C. M. Ashbaugh2, L. Remy3, D. Aholt3, C. Miller3, S. Ye3, D. K. Hathaway4, D. Clark4, V. S. Staggs5, K. Goggin6, R. J. Ellis7, C. L. Russell3

    1Surgery/Urology, University of Missouri School of Medicine, Columbia, MO, 2Transplant, University of Missouri Health Care, Columbia, MO, 3School of Nursing and Health Studies, University of Missouri-Kansas City, Kansas City, MO, 4College of Nursing, University of Tennessee HSC, Memphis, TN, 5Health Services and Outcomes Research, Children's Mercy Kansas City, Kansas City, MO, 6Health Services and Outcomes Research, Children's Mercy Kansas City and Schools of Medicine and Pharmacy, University of Missouri-Kansas City, Kansas City, MO, 7School of Nursing, Indiana University, Indianapolis, IN

    *Purpose: Medication non-adherence is an obdurate problem associated with poor outcomes and staggering costs. Even with multi-faceted interventions, effect sizes reported in meta-analyses of medication…
  • 2019 American Transplant Congress

    Burden of Respiratory Virus Infections in Solid-Organ Transplant Recipients: A Nationwide Multi-Season Cohort Study

    M. Mombelli1, D. Neofytos2, J. Aubert1, C. Benden3, C. Berger3, K. Boggian4, A. Egli5, P. Gasche2, H. Hirsch5, C. Hirzel6, N. Mueller3, C. Van Delden2, O. Manuel1

    1CHUV, Lausanne, Switzerland, 2HUG, Geneva, Switzerland, 3USZ, Zurich, Switzerland, 4KSSG, St. Gallen, Switzerland, 5USB, Basel, Switzerland, 6ISB, Bern, Switzerland

    *Purpose: Respiratory virus infections (RVI) are common in solid-organ transplant recipients (SOTr) and are caused by a wide range of viruses. However, beside influenza, little…
  • « Previous Page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 84
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences